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Letters
Long-lasting treated mosquito
nets: a breakthrough in
malaria prevention
Editor – Regardless of views expressed
recently in the Bulletin (1–2), insecticide-
treated mosquito nets are currently the
only viable option to prevent malaria
transmission in large parts of Africa.
To be effective, mosquito nets have to
be treated by dipping them in suitable
insecticides at least once a year. Less
than 5% of the nets currently used in
Africa are properly treated or re-treated.
Looking for practical solutions, WHO
stimulated industry to produce long-
lasting insecticide-treated mosquito nets
(LLNs), using new bioactive fabric
technologies. Long-lasting nets are
treated only once, at factory level. The
insecticide can resist multiple washes
and is released over time to the surface
of the netting fibres. The major criteria
for LLNs is that efficacy should last as
long as the average lifespan of the net,
i.e. 4–5 years. Compared with nets
treated by conventional dipping, LLNs
have several important advantages: no
need for re-treatment; reduced insecti-
cide consumption; and minimum
potential environmental impact: release
of insecticide in natural water bodies
during washing is greatly reduced.
There are two LLNs commercially
available, currently being evaluated
through the WHO Pesticide Evaluation
Scheme (WHOPES). R&D is crucial
in further improving the technology.
Second-generation LLNs are now
emerging with even better performance.
They are major technical breakthroughs,
significantly changing prospects for
successful implementation of ITN
programmes, especially in Africa.
To protect the most vulnerable
groups in Africa (children under five,
pregnant women and people living
below the poverty line) and to meet the
objective set by the Heads of State of
African countries in Abuja (60% of net
coverage by 2005), it is estimated that
a total of 115million nets will be needed.
To reach full coverage, ideally by the year
2007, an additional 97 million nets
will be needed and maintenance of this
coverage after 2007 will require 28 to
30 million nets per year. Protection of
the whole population at risk of malaria in
Africa would require about twice these
numbers.
When envisaging further develop-
ment of LLNs, it is important to
involve the net industry in Africa and
to facilitate technology transfer.
Strengthening production capacity of
LLNs in Africa and further reducing the
price through well-targeted public–
private partnerships will be an effective
way to go to scale, reduce the malaria
burden, and contribute to poverty
alleviation. It also offers an opportunity
to African countries to develop a
profitable ITN economy and to play
an increasing role in global efforts to
roll back malaria. n
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